XML 30 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Restructuring, Acquisition, and Related Costs
6 Months Ended
Jun. 28, 2024
Restructuring and Related Activities [Abstract]  
Restructuring, Acquisition, and Related Costs

14. Restructuring, Acquisition, and Related Costs

The following table summarizes restructuring, acquisition, and related costs in the accompanying consolidated statements of operations (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

2024 restructuring

$

2,523

 

 

$

 

 

$

3,071

 

 

 

 

2022 restructuring

 

 

 

 

677

 

 

 

 

 

 

2,874

 

2020 restructuring

 

 

 

 

459

 

 

 

 

 

 

733

 

Total restructuring charges

 

2,523

 

 

 

1,136

 

 

 

3,071

 

 

 

3,607

 

Acquisition and related charges

 

20

 

 

 

98

 

 

 

1,755

 

 

 

103

 

Total restructuring, acquisition, and related costs

$

2,543

 

 

$

1,234

 

 

$

4,826

 

 

$

3,710

 

2024 Restructuring

As a result of the Company’s acquisitions and ongoing integration activities, the Company initiated the 2024 restructuring program in the first quarter of 2024 in order to reduce operating complexity. During the three and six months ended June 28, 2024, the Company recorded $2.5 million and $3.1 million, respectively, in severance, facility related and other charges in connection with the 2024 restructuring program. As of June 28, 2024, the Company had incurred cumulative costs of $3.1 million related to this restructuring program. The Company anticipates substantially completing the 2024 restructuring program by the end of 2024 and expects to incur additional restructuring charges of $3.0 million to $4.0 million related to the 2024 restructuring program.

The following table summarizes restructuring costs associated with the 2024 restructuring program by reportable segment (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 28,

 

 

June 30,

 

 

June 28,

 

 

June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Precision Medicine and Manufacturing

$

1,853

 

 

$

 

 

$

1,888

 

 

$

 

Medical Solutions

 

151

 

 

 

 

 

 

357

 

 

 

 

Robotics and Automation

 

166

 

 

 

 

 

 

410

 

 

 

 

Unallocated Corporate and Shared Services

 

353

 

 

 

 

 

 

416

 

 

 

 

Total

$

2,523

 

 

$

 

 

$

3,071

 

 

$

 

Rollforward of Accrued Expenses Related to Restructuring

The following table summarizes the accrual activities, by component, related to the Company’s restructuring plans recorded in the accompanying consolidated balance sheets (in thousands):

 

Total

 

 

Employee Related

 

 

Facility Related

 

 

Other

 

Balance at December 31, 2023

$

2,850

 

 

$

1,038

 

 

$

1,680

 

 

$

132

 

Restructuring charges

 

3,071

 

 

 

2,231

 

 

 

659

 

 

 

181

 

Cash payments

 

(2,447

)

 

 

(992

)

 

 

(1,163

)

 

 

(292

)

Non-cash write-offs and other adjustments

 

(40

)

 

 

(12

)

 

 

(32

)

 

 

4

 

Balance at June 28, 2024

$

3,434

 

 

$

2,265

 

 

$

1,144

 

 

$

25

 

Acquisition and Related Charges

Acquisition costs in connection with business combinations, including finders’ fees, legal, valuation, and other professional or consulting fees, totaled less than $0.1 million and $1.8 million for the three and six months ended June 28, 2024, respectively, and $0.1 million for both the three and six months ended June 30, 2023. The majority of acquisition and related costs for the three and six months ended June 28, 2024 and the three and six months ended June 30, 2023 were included in the Company’s unallocated Corporate and Shared Services reportable segment.